drugset / Trial / NCT02868814
The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate the Efficacy and safety of pregabalin sustained release tablets versus placebo for fibromyalgia
Timeline
- Start
- 2016-05
- Primary completion
- 2019-05
- Completion
- 2019-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 330 mg | Oral |
| Subject | Pregabalin | Small molecule | 495 mg | Oral |